Literature DB >> 6753905

Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.

U Dahlström, B E Karlberg.   

Abstract

1 In an open study the clinical short-term and long-term effects of low-dose captopril (mean daily dose 45 +/- 15 mg) were evaluated in 20 patients with severe congestive heart failure refractory to conventional treatment with digitalis and diuretics. 2 After two weeks' treatment 16 out of 20 patients showed an improvement in New York Heart Association functional class, followed by a significant reduction in body weight and heart volume. The ratio between urinary sodium and potassium excretion was significantly increased and the urinary aldosterone excretion was significantly decrease. In 10 of the patients the initial effects were sustained during long-term treatment (6 +/- 2 months). 3 In conclusion, captopril may be a useful therapeutic adjunct for the long-term treatment of patients with severe heart failure or when conventional treatment has failed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6753905      PMCID: PMC1427529          DOI: 10.1111/j.1365-2125.1982.tb02082.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

Review 1.  Determinants and prediction of transmural myocardial perfusion.

Authors:  J I Hoffman
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

2.  Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril.

Authors:  R K Ferguson; P H Vlasses
Journal:  Am Heart J       Date:  1981-05       Impact factor: 4.749

3.  Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.

Authors:  V J Dzau; W S Colucci; N K Hollenberg; G H Williams
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

4.  Effect of captopril on renal function in patients with congestive heart failure.

Authors:  G L Pierpont; G S Francis; J N Cohn
Journal:  Br Heart J       Date:  1981-11

5.  Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.

Authors:  R Ader; K Chatterjee; T Ports; B Brundage; B Hiramatsu; W Parmley
Journal:  Circulation       Date:  1980-05       Impact factor: 29.690

6.  Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.

Authors:  N A Awan; M K Evenson; K E Needham; A Win; D T Mason
Journal:  Am Heart J       Date:  1981-01       Impact factor: 4.749

7.  Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.

Authors:  C Curtiss; J N Cohn; T Vrobel; J A Franciosa
Journal:  Circulation       Date:  1978-11       Impact factor: 29.690

8.  Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.

Authors:  V J Dzau; W S Colucci; G H Williams; G Curfman; L Meggs; N K Hollenberg
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

9.  Improvement of chronic congestive heart-failure by oral captopril.

Authors:  G A Turini; H R Brunner; M Gribic; B Waeber; H Gavras
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

10.  Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment.

Authors:  D N Sharpe; J E Douglas; R J Coxon; B Long
Journal:  Lancet       Date:  1980-11-29       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.